GSA CAPITAL PARTNERS LLP - IMMUNITYBIO INC ownership

IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 144 filers reported holding IMMUNITYBIO INC in Q4 2022. The put-call ratio across all filers is 1.25 and the average weighting 0.1%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of IMMUNITYBIO INC
ValueSharesWeighting
Q4 2022$112
-100.0%
22,043
-74.0%
0.01%
-70.2%
Q2 2022$316,000
-32.3%
84,884
+2.0%
0.05%
-25.4%
Q1 2022$467,000
-40.6%
83,204
-35.6%
0.06%
-36.4%
Q4 2021$786,000129,2600.10%
Other shareholders
IMMUNITYBIO INC shareholders Q4 2022
NameSharesValueWeighting ↓
ALLEN HOLDING INC /NY 687,571$4,180,0000.56%
HARBOURVEST PARTNERS LLC 335,709$2,041,0000.26%
MERIDIAN INVESTMENT COUNSEL INC. 96,433$586,0000.20%
SHEETS SMITH WEALTH MANAGEMENT 152,276$926,0000.12%
GSA CAPITAL PARTNERS LLP 129,260$786,0000.10%
Clearwater Capital Advisors, LLC 140,551$855,0000.09%
Virtus ETF Advisers LLC 28,969$176,0000.07%
XTX Topco Ltd 19,159$116,0000.07%
LIBERTY ONE INVESTMENT MANAGEMENT, LLC 49,464$301,0000.04%
Vident Investment Advisory, LLC 168,476$1,024,0000.03%
View complete list of IMMUNITYBIO INC shareholders